Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 3:53 AM
Ignite Modification Date:
2025-12-26 @ 2:43 AM
NCT ID:
NCT05027802
Pre Assignment Details:
This study consisted of an Inclusion visit which included signing of informed consent form (Day 1), a continuous dosing treatment period (including a follow-up visit every 6 months), and an end of study/early withdrawal visit. Participants were eligible for the study whether they received chronic or flare-up treatment in the parent study at the time of transition.
Recruitment Details:
This single-arm, rollover, multicenter, Phase III, open-label study was conducted at 12 investigational sites in 9 countries from 14-Mar-2022 to 30-Nov-2024 in participants \>=14 years with fibrodysplasia ossificans progressiva (FOP) who had completed parent study PVO-1A-301 (NCT03312634) or PVO-1A-202 (NCT02279095)/PVO-1A-204 (NCT02979769) and continued to benefit from palovarotene therapy. A total of 61 participants were enrolled in the study of which 59 received treatment.
Study:
NCT05027802
Study Brief:
Results Section:
NCT05027802